mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-07 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |